Table 4.
Overall (N = 40) | Improvement (N = 18) | No Improvement (N = 22) | |||||
---|---|---|---|---|---|---|---|
N | % | N | % | N | % | P-value* | |
Time to post-ITS audiogram | |||||||
≤5 weeks | 27 | 68 | 9 | 33 | 18 | 67 | 0.03 |
>5 weeks | 13 | 33 | 9 | 69 | 4 | 31 | |
Age, years | |||||||
Mean (SD) | 54 | (18) | 50 | (18) | 58 | (18) | 0.17 |
Gender | |||||||
Male | 20 | 50 | 8 | 40 | 12 | 60 | 0.53 |
Female | 20 | 50 | 10 | 50 | 10 | 50 | |
Ear | |||||||
Left | 26 | 65 | 10 | 38 | 16 | 62 | 0.26 |
Right | 14 | 35 | 8 | 57 | 6 | 43 | |
Days from onset to ITS | |||||||
≤21 | 24 | 60 | 12 | 50 | 12 | 50 | 0.02 |
>21 | 16 | 40 | 6 | 38 | 10 | 63 | |
Prior oral steroids | |||||||
Yes | 25 | 63 | 9 | 50 | 9 | 50 | 0.14 |
No | 15 | 38 | 9 | 36 | 16 | 64 | |
Vertigo | |||||||
Yes | 17 | 43 | 11 | 65 | 6 | 35 | 0.03 |
No | 23 | 58 | 7 | 30 | 16 | 70 | |
Tinnitus | |||||||
Yes | 27 | 68 | 14 | 52 | 13 | 48 | 0.21 |
No | 13 | 33 | 4 | 31 | 9 | 69 |
*P-values were computed using t-test for continuous characteristics and chi-square tests for categorical. ITS: intratympanic steroids; N: frequency; SD: standard deviation.